Institute of Paediatric Haematology and Oncology, 1 Place Professeur Joseph Renaut, 69008, Lyon, France.
Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, Scotland.
Eur J Pediatr. 2021 Sep;180(9):2921-2930. doi: 10.1007/s00431-021-04056-5. Epub 2021 Apr 9.
Bacterial infections remain a major cause of morbidity and mortality in immunocompromised children. From the onset of fever, an early administration of broad-spectrum antibiotics is begun; this strategy could induce emergence of multi-drug resistant bacteria (MDR). We describe the incidence and microbiological spectrum, including MDR bacteria of bacterial documented blood-stream infections (BSI) in immunocompromised children. A retrospective, descriptive study was conducted in a tertiary referral centre in France from January 2014 to December 2017. Our cohort included a large scale of patients with febrile neutropenia: haematological and oncological malignancies, haematopoietic stem cell transplantations, severe combined immunodeficiency syndromes. BSI were defined by positive blood culture samples associated with fever. Among 760 febrile neutropenia episodes in 7301 admitted patients, we identified 310 documented BSI with a mean of 7.4 BSI/1000 patient bed days. Only 2.9% BSIs were caused by MDR bacteria, none vancomycin resistant. Coagulase-negative staphylococci were identified in 49.7% BSI and Staphylococcus aureus caused 6.5% infections. Gram-negative bacilli accounted for 21.6% of isolated bacteria, Pseudomonas for 4.8%. The incidence of BSI annually decreased by 0.75% (p = 0.002).Conclusion: With a step-down strategy at 48 h of initial broad-spectrum antibiotic therapy, we reported a low number of MDR bacteria, no deaths related to BSI. What is Known: • Bacterial bloodstream infections are a leading cause of morbidity and mortality in immunocompromised children • Multi-drug resistant bacteria are emerging worldwide. What is New: • Initial broad-spectrum antibiotic therapy with a step-down strategy at 48 h: no deaths related to bloodstream infections with a low number of resistant bacteria. • Parental and nurse stewardship to decrease bloodstream infections incidence with a drop of staphylococcal infections.
细菌感染仍然是免疫功能低下儿童发病和死亡的主要原因。从发热开始,就开始早期给予广谱抗生素;这种策略可能会导致多药耐药菌(MDR)的出现。我们描述了免疫功能低下儿童中确诊的血流感染(BSI)的发生率和微生物谱,包括 MDR 细菌。本研究是在法国的一家三级转诊中心进行的回顾性描述性研究,时间为 2014 年 1 月至 2017 年 12 月。我们的队列包括大量发热性中性粒细胞减少症患者:血液系统恶性肿瘤和恶性肿瘤、造血干细胞移植、严重联合免疫缺陷综合征。BSI 通过与发热相关的阳性血培养样本定义。在 7301 名入院患者的 760 例发热性中性粒细胞减少症发作中,我们确定了 310 例确诊的 BSI,平均每 1000 个患者住院日有 7.4 例 BSI。只有 2.9%的 BSI 由 MDR 细菌引起,没有耐万古霉素的细菌。49.7%的 BSI 由凝固酶阴性葡萄球菌引起,6.5%的感染由金黄色葡萄球菌引起。革兰氏阴性杆菌占分离细菌的 21.6%,其中假单胞菌占 4.8%。BSI 的年发生率每年下降 0.75%(p=0.002)。结论:在初始广谱抗生素治疗 48 小时后采用降阶梯策略,我们报告了 MDR 细菌数量较少,没有与 BSI 相关的死亡。已知情况:• 细菌血流感染是免疫功能低下儿童发病和死亡的主要原因。• 多药耐药菌在全球范围内不断出现。新情况:• 初始广谱抗生素治疗,48 小时后采用降阶梯策略:无与血流感染相关的死亡,耐药菌数量较少。• 父母和护士的管理可以减少血流感染的发生率,降低葡萄球菌感染的发生率。